[Adamson IY, Bowden DH. (1974). The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol77: 185–197.]Search in Google Scholar
[Agin K. (2004). Comparison of prevalence of osteoporosis in patients with asthma following chemical injury in patients with asthma Sulfur-mustard non chemical victims. Mil Res J4: 419–422.]Search in Google Scholar
[Agusti A, Soriano JB. (2008). COPD as a systemic disease. COPD: Journal of Chronic Obstructive Pulmonary Disease5: 133–138.10.1080/15412550801941349]Open DOISearch in Google Scholar
[Aldonyte R, Eriksson S, Piitulainen E, Wallmark A, Janciauskiene S. (2004). Analysis of systemic biomarkers in COPD patients. Copd1: 155–164.]Search in Google Scholar
[Anderson GP. (2006). COPD, asthma and C-reactive protein. Eur Respir J27: 874–876.10.1183/09031936.06.00029306]Open DOISearch in Google Scholar
[Attaran D, Lari SM, Khajehdaluee M, Ayatollahi H, Towhidi M, Asnaashari A, Marallu HG, Mazloomi M, Balali-Mood M. (2009). Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol28: 739–745.10.1177/0960327109354311]Open DOISearch in Google Scholar
[Attaran D, Lari SM, Towhidi M, Marallu HG, Ayatollahi H, Khajehdaluee M, Ghanei M, Basiri R. (2010). Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis5: 335–340.]Search in Google Scholar
[Balali-Mood M, Afshari R, Zojaji R, Kahrom H, Kamrani M, Attaran D, Mousavi SR, Zare GA. (2011). Delayed toxic effects of sulfur mustard on respiratory tract of Iranian veterans. Hum Exp Toxicol30(9): 1141–1149.10.1177/0960327110389501]Open DOISearch in Google Scholar
[Barnes PJ, Celli BR. (2009). Systemic manifestations and comorbidities of COPD. Eur Respir J33: 1165–1185.10.1183/09031936.00128008]Open DOISearch in Google Scholar
[Barnes TC, Anderson ME, Moots RJ. (2011). The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol2011: 721608.]Search in Google Scholar
[Batra S, Balamayooran G, Sahoo MK. (2011). Nuclear factor-kappaB: a key regulator in health and disease of lungs. Arch Immunol Ther Exp (Warsz)59: 335–351.]Search in Google Scholar
[Bayat N, Aslani J. (2010). Comparing the bone mineral density in chemical injures and non-chemical asmatic patients. Trauma Monthly2011: 105–110.]Search in Google Scholar
[Biskobing DM. (2002). COPD and osteoporosis. Chest121: 609–620.]Search in Google Scholar
[Blackwell TS, Christman JW. (1997). The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol17: 3–9.]Search in Google Scholar
[Calderon TM, Berman JW. (2005). Overview and history of chemokines and their receptors. Current Topics in Membranes55: 1–47.]Search in Google Scholar
[Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, investigators T. (2007). Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med356: 775–789.]Search in Google Scholar
[Carter JD, Patel S, Sultan FL, Thompson ZJ, Margaux H, Sterrett A, Carney G, Murphy N, Huang Y, Valeriano J, Vasey FB. (2008). The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease. Respir Med102: 1165–1172.]Search in Google Scholar
[Comhair SA, Bhathena PR, Dweik RA, Kavuru M, Erzurum SC. (2000). Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet355: 624.]Search in Google Scholar
[Comhair SA, Erzurum SC. (2002). Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol283: L246–255.]Search in Google Scholar
[Dahl M, Nordestgaard BG. (2009). Markers of early disease and prognosis in COPD. Int J Chron Obstruct Pulmon Dis4: 157–167.]Search in Google Scholar
[Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. (2007). C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine175: 250–255.]Search in Google Scholar
[Dayhimi I, Bahar K, Eliasy H. (1988). The effect of sulfur mustard gas (SMG) on the immune system. In: The First International Medical Congress on Chemical Warfare Agents in Iran Mashhad, Iran: Mashhad University of Medical Sciences.]Search in Google Scholar
[de Moraes MR, da Costa AC, Correa Kde S, Junqueira-Kipnis AP, Rabahi MF. (2014). Interleukin-6 and interleukin-8 blood levels’ poor association with the severity and clinical profile of ex-smokers with COPD. Int J Chron Obstruct Pulmon Dis9: 735–743.]Search in Google Scholar
[Denk A, Wirth T, Baumann B. (2000). NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev11: 303–320.10.1016/S1359-6101(00)00009-5]Open DOISearch in Google Scholar
[Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer2: 161–174.10.1038/nrc74511990853]Open DOISearch in Google Scholar
[Ekstrand-Hammarstrom B, Wigenstam E, Bucht A. (2011). Inhalation of alkylating mustard causes long-term T cell-dependent inflammation in airways and growth of connective tissue. Toxicology280: 88–97.]Search in Google Scholar
[Emad A, Rezaian GR. (1999). Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest115: 1346–1351.]Search in Google Scholar
[Evison D, Hinsley D, Rice P. (2002). Regular review: chemical weapons. BMJ: British Medical Journal324: 332.]Search in Google Scholar
[Fakhraddin F, Reza SA, Yahya D, Akbar KZA, Mahdi C. (1999). Does Sulfur Mustard (HD) have an accelerating effect on CABG in HD-exposed people? Is it a link? Medical Science and Technology48: RA11–RA13.]Search in Google Scholar
[Firoozabadi MD, Shahriary A, Rahmani H. (2017). Mustard lung anesthesia; general anesthesia for patients with chronic obstructive pulmonary disease due to sulphur mustard exposure. Minerva Pneumol56: 254–257.]Search in Google Scholar
[Fooladi AAI, Nourani MR, Yazdani S. (2012). Lung and Systemic Inflammation in COPD: INTECH Open Access Publisher.]Search in Google Scholar
[Foronjy RF, Okada Y, Cole R, D’Armiento J. (2003). Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung. Am J Physiol Lung Cell Mol Physiol284: L727–737.]Search in Google Scholar
[Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. (1998). Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest78: 687–698.]Search in Google Scholar
[Geddes EL, Reid WD, Crowe J, O’Brien K, Brooks D. (2005). Inspiratory muscle training in adults with chronic obstructive pulmonary disease: a systematic review. Respir Med99: 1440–1458.]Search in Google Scholar
[Ghanei M, Adibi I, Farhat F, Aslani J. (2008). Late respiratory effects of sulfur mustard: how is the early symptoms severity involved? Chronic respiratory disease5: 95–100.10.1177/147997230708719118539723]Search in Google Scholar
[Ghanei M, Harandi AA. (2007). Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol19: 451–456.10.1080/0895837060117499017365048]Open DOISearch in Google Scholar
[Ghasemi H, Ghazanfari T, Babaei M, Soroush MR, Yaraee R, Ghassemi-Broumand M, Javadi MA, Foroutan A, Mahdavi MR, Shams J, Pourfarzam S, Moaiedmohseni S, Nadoushan MR, Owlia P, Panahi Y, Hassan ZM, Faghihzadeh S. (2008). Long-term ocular complications of sulfur mustard in the civilian victims of Sardasht, Iran. Cutan Ocul Toxicol27: 317–326.10.1080/1556952080240438219037764]Open DOISearch in Google Scholar
[Ghasemi H, Ghazanfari T, Yaraee R, Ghassemi-Broumand M, Soroush MR, Pourfarzam S, Masdari Z, Faghihzadeh S, Babaei M, Javadi MA. (2009). Evaluation of relationship between the serum levels of inflammatory mediators and ocular injuries induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol9(13–14): 1494–1498.]Search in Google Scholar
[Ghasemi H, Mostafaie A, Yaraee R, Hassan ZM, Rezaei A, Mahmoudi M, Faghihzadeh S, Soroush MR, Ardestani SK, Babaei M, Jalali-Nadoushan M, Khamesipour A, Ghassemi-Broumand M, Ghazanfari T. (2013). Association of serum immunoglobulins levels and eye injuries in sulfur mustard exposed: Sardasht-Iran Cohort Study. Int Immunopharmacol17: 944–951.10.1016/j.intimp.2012.12.027]Open DOISearch in Google Scholar
[Ghazanfari T, Mostafaie A, Yaraee R, Pourfarzam S, Faghihzadeh S, Rezaei A, Mahmoudi M, Vaez-Mahdavi MR, Moaiedmohseni S, Soroush MR, Naghizadeh MM, Faghihzadeh E, Hassan ZM. (2013). Are serum levels of immunoglobulin classes and IgG subclasses involved in delayed pulmonary complications induced by sulfur mustard? Sardasht-Iran Cohort Study. Int Immunopharmacol17: 936–943.10.1016/j.intimp.2012.12.028]Open DOISearch in Google Scholar
[Ghazanfari T, Yaraee R, Kariminia A, Ebtekar M, Faghihzadeh S, Vaez-Mahdavi MR, Rezaei A, Vojgani M, Soroush MR, Kermani-Jalilvand A. (2009). Alterations in the serum levels of chemokines 20years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol9(13–14): 1471–6.]Search in Google Scholar
[Ghotbi L, Hassan Z. (2002). The immunostatus of natural killer cells in people exposed to sulfur mustard. Int Immunopharmacol2: 981–985.10.1016/S1567-5769(02)00053-X]Open DOISearch in Google Scholar
[Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. (2009). Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J34: 209–218.10.1183/09031936.50130408]Open DOISearch in Google Scholar
[Groot Kormelink T, Pardo A, Knipping K, Buendia-Roldan I, Garcia-de-Alba C, Blokhuis BR, Selman M, Redegeld FA. (2011). Immunoglobulin free light chains are increased in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. PLoS One6: e25392.]Search in Google Scholar
[Hammad DR, Elgazzar AG, Essawy TS, El Sameie SAA. (2015). Evaluation of serum interleukin-1 beta as an inflammatory marker in COPD patients. Egyptian Journal of Chest Diseases and Tuberculosis64: 347–352.]Search in Google Scholar
[Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloii MR, Ghazanfari T. (2006). Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol5: 101–108.]Search in Google Scholar
[Hayden MS, Ghosh S. (2008). Shared principles in NF-kappaB signaling. Cell132: 344–362.]Search in Google Scholar
[Hefazi M, Attaran D, Mahmoudi M, Balali-Mood M. (2005). Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol17: 587–592.10.1080/08958370591000591]Open DOISearch in Google Scholar
[Heidari A, Sheikhi MA, Rahmani H. (2016). Inflammatory status of Non-Smoker Sulphur Mustard exposed Patient with Cancer candidate for Coronary artery bypass grafting Surgery. Int J Pharm Res Allied Sci5: 196–198.]Search in Google Scholar
[Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. (2009). Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med103(8): 1231–1238.]Search in Google Scholar
[Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA. (2006). Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med174(8): 867–874.]Search in Google Scholar
[Husain K, Dube SN, Sugendran K, Singh R, Das Gupta S, Somani SM. (1996). Effect of topically applied sulphur mustard on antioxidant enzymes in blood cells and body tissues of rats. J Appl Toxicol16: 245–248.10.1002/(SICI)1099-1263(199605)16:3<245::AID-JAT339>3.0.CO;2-3]Open DOISearch in Google Scholar
[Chauhan S, Gupta MK, Goyal A, Dasgupta DJ. (1990). Alterations in immunoglobulin & complement levels in chronic obstructive pulmonary disease. Indian J Med Res92: 241–245.]Search in Google Scholar
[Chung KF. (2005). Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy4: 619–625.10.2174/156801005774912806]Open DOISearch in Google Scholar
[Imani S, Panahi Y, Salimian J, Fu J, Ghanei M. (2015). Epigenetic: A missing paradigm in cellular and molecular pathways of sulfur mustard lung: a prospective and comparative study. Iran J Basic Med Sci18: 723–736.]Search in Google Scholar
[Imanifooladi A A, Yazdani S, Nourani MR. (2010). The role of nuclear factor-kappaB in inflammatory lung disease. Inflamm Allergy Drug Targets9(3): 197–205.10.2174/187152810792231904]Open DOISearch in Google Scholar
[Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. (1999). Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest116: 1616–1624.]Search in Google Scholar
[Irwin CR, Myrillas TT, Traynor P, Leadbetter N, Cawston TE. (2002). The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts. J Periodontol73: 741–747.]Search in Google Scholar
[Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, Ouchi Y. (2000). Neither IL-1 β, IL-1 receptor antagonist, nor TNF-α polymorphisms are associated with susceptibility to COPD. Respir Med94: 847–851.]Search in Google Scholar
[Jorgensen NR, Schwarz P. (2008). Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med14: 122–127.10.1097/MCP.0b013e3282f4efb6]Open DOISearch in Google Scholar
[Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. (2008a). Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung186: 403–409.10.1007/s00408-008-9106-6]Search in Google Scholar
[Karadag F, Kirdar S, Karul AB, Ceylan E. (2008b). The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med19(2): 104–108.10.1016/j.ejim.2007.04.026]Open DOISearch in Google Scholar
[Karbasi-Afshar R, Shahmari A, Madadi M, Poursaleh Z, Saburi A. (2013). Coronary angiography findings in lung injured patients with sulfur mustard compared to a control group. Ann Card Anaesth16: 188–192.]Search in Google Scholar
[Kelley WN, Harris ED, Ruddy S, Sledge CB. (1997). Textbook of rheumatology: WB Saunders Philadelphia.]Search in Google Scholar
[Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. (2003). Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med45(11): 1136–1143.]Search in Google Scholar
[Kiani A, Mostafaie A, Shirazi FH, Ghazanfari T. (2013). Serum profiles of matrix metalloproteinases and their tissue inhibitors in long-term pulmonary complication induced by sulfur mustard: Sardasht-Iran Cohort Study (SICS). Int Immunopharmacol17(3): 964–967.10.1016/j.intimp.2012.12.025]Open DOISearch in Google Scholar
[Kim H, Liu X, Kohyama T, Kobayashi T, Conner H, Abe S, Fang Q, Wen F-Q, Rennard SI. (2004). Cigarette smoke stimulates MMP-1 production by human lung fibroblasts through the ERK1/2 pathway. COPD1(1): 13–23.]Search in Google Scholar
[Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F. (2004). Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax59: 892–896.]Search in Google Scholar
[Kopff M, Zakrzews ka I, Strzelczyk M, Klem J, Dubiecki W. (1993). Superoxide dismutase and catalase activity in psoriatic patients treated topically with ointment containing 2-chloroethyl-3-chloropropyl sulfide. Pol J Pharmacol46(5): 439–444.]Search in Google Scholar
[Kraus VB, Stabler TV, Luta G, Renner JB, Dragomir AD, Jordan JM. (2007). Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis. Osteoarthritis Cartilage15(8): 966–971.]Search in Google Scholar
[Krumbhaar EB, Krumbhaar HD. (1919). The Blood and Bone Marrow in Yelloe Cross Gas (Mustard Gas) Poisoning: Changes produced in the Bone Marrow of Fatal Cases. J Med Res40: 497–508.]Search in Google Scholar
[Lahousse L, Loth DW, Joos GF, Hofman A, Leufkens HG, Brusselle GG, Stricker BH. (2013). Statins, systemic inflammation and risk of death in COPD: the Rotterdam study. Pulm Pharmacol Ther26: 212–217.10.1016/j.pupt.2012.10.008]Open DOISearch in Google Scholar
[Lai Y, Liu X, Zeng Y, Zhang Y, Shen Y, Liu Y. (2012). Interleukin-8 induces the endothelial cell migration through the Rac1/RhoA-p38MAPK pathway. Cell51: 38MAPK.]Search in Google Scholar
[Langen RC, Korn S H, Wouters EF. (2003). ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med35: 226–235.]Search in Google Scholar
[Lari SM, Attaran D, Towhidi M. (2012). COPD Due to Sulfur Mustard (Mustard Lung): INTECH Open Access Publisher.]Search in Google Scholar
[Laskin DL, Sunil VR, Laumbach RJ, Kipen HM. (2007). Inflammatory cytokines and lung toxicity. In: Cytokines in Human Health, pp 83–112: Springer.10.1007/978-1-59745-350-9_6]Open DOISearch in Google Scholar
[Lee KY, Ho SC, Chan YF, Wang CH, Huang CD, Liu WT, Lin SM, Lo YL, Chang YL, Kuo LW, Kuo HP. (2012). Reduced nuclear factor-kappaB repressing factor: a link toward systemic inflammation in COPD. Eur Respir J40: 863–873.10.1183/09031936.00146811]Open DOISearch in Google Scholar
[Lehmann W, Edgar CM, Wang K, Cho TJ, Barnes GL, Kakar S, Graves DT, Rueger JM, Gerstenfeld LC, Einhorn TA. (2005). Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone36: 300–310.10.1016/j.bone.2004.10.010]Open DOISearch in Google Scholar
[Levitt JM, Lodhi IJ, Nguyen PK, Ngo V, Clift R, Hinshaw DB, Sweeney JF. (2003). Low-dose sulfur mustard primes oxidative function and induces apoptosis in human polymorphonuclear leukocytes. Int Immunopharmacol3: 747–756.10.1016/S1567-5769(03)00075-4]Open DOISearch in Google Scholar
[Ley K. (2003). The role of selectins in inflammation and disease. Trends Mol Med9: 263–268.10.1016/S1471-4914(03)00071-6]Open DOISearch in Google Scholar
[Littner MR. (2011). In the clinic. Chronic obstructive pulmonary disease. Ann Intern Med154: ITC4-1-ITC4-15; quiz ITC14-16.]Search in Google Scholar
[MacNee W. (2005). Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc2: 50–60.]Search in Google Scholar
[Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. (2005). Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol5: 1479–1485.10.1016/j.intimp.2005.04.00315953574]Open DOISearch in Google Scholar
[Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Zhang X, Vessey R, Walker TG, Celli BR, Sin DD. (2008). Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J32: 1451–1457.10.1183/09031936.0015320718799503]Search in Google Scholar
[Miedema I, Feskens EJ, Heederik D, Kromhout D. (1993). Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen Study. Am J Epidemiol138: 37–45.]Search in Google Scholar
[Mirbagher Ajorpaz N, Rezaei M. (2009). The Effects of pulmonary rehabilitation techniques on the clinical status of patients with moderate severity chronic obstructive pulmonary diseases (COPD) at University Hospitals of Isfahan in 2006–7. ZUMS Journal17: 1–12.]Search in Google Scholar
[Mishra NC, Rir-sima-ah J, Grotendorst GR, Langley RJ, Singh SP, Gundavarapu S, Weber WM, Pena-Philippides JC, Duncan MR, Sopori ML. (2012). Inhalation of sulfur mustard causes long-term T cell-dependent inflammation: possible role of Th17 cells in chronic lung pathology. Int Immunopharmacol13: 101–108.10.1016/j.intimp.2012.03.010334049722465472]Open DOISearch in Google Scholar
[Moermans C, Heinen V, Nguyen M, Henket M, Sele J, Manise M, Corhay JL, Louis R. (2011). Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine56: 298–304.10.1016/j.cyto.2011.07.01021880505]Open DOISearch in Google Scholar
[Moin A, Ghazanfari T, Davoudi SM, Emadi N, Panahi Y, Hassan ZM, Soroush MR, Khateri S, Amini R, Naghizadeh MM. (2009). Long-term skin findings of sulfur mustard exposure on the civilians of Sardasht, Iran. Toxin Reviews28: 24–29.10.1080/15569540802689311]Open DOISearch in Google Scholar
[Montano M, Sansores RH, Becerril C, Cisneros J, Gonzalez-Avila G, Sommer B, Ochoa L, Herrera I, Ramirez-Venegas A, Ramos C. (2014). FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure. Respir Res15: 74.]Search in Google Scholar
[Naghii MR. (2002). Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil Med167: 573–575.]Search in Google Scholar
[Nussbaumer-Ochsner Y, Rabe KF. (2011). Systemic manifestations of COPD. Chest139: 165–173.]Search in Google Scholar
[O’Keeffe S, Gzel A, Drury R, Cullina M, Greally J, Finnegan P. (1991). Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease. Eur Respir J4: 932–936.]Search in Google Scholar
[Paromov V, Suntres Z, Smith M, Stone WL. (2007). Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J Burns Wounds7: e7.]Search in Google Scholar
[Parvizpour F, Ghazanfari T, Salimi H, Faghihzadeh S, Yaraee R, Sharifnia Z, Soroosh MR, Naghizadeh MM. (2011). NFκB gene expression survey in peripheral blood cell of sardasht warfare agent victims 20 years after exposure to sulfur mustard. Tebe-E-Janbaz3(12): 38–47.]Search in Google Scholar
[Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B. (2007). Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax62: 595–601.10.1136/thx.2006.064428211724417356059]Open DOISearch in Google Scholar
[Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR. (2006). C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax61: 23–28.10.1136/thx.2005.042200208071416143583]Open DOISearch in Google Scholar
[Pourfarzam S, Ghazanfari T, Merasizadeh J, Ghanei M, Azimi G, Araghizadeh H, Foroutan A, Shams J, Ghasemi H, Yaraee R. (2009a). Long-term pulmonary complications in sulfur mustard victims of Sardasht, Iran. Toxin Reviews28: 8–13.10.1080/15569540802689220]Open DOISearch in Google Scholar
[Pourfarzam S, Ghazanfari T, Yaraee R, Ghasemi H, Hassan ZM, Faghihzadeh S, Ardestani SK, Kariminia A, Fallahi F, Soroush MR, Merasizadeh J, Mahlojirad M, Naghizadeh MM, Ghanei M. (2009b). Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol9: 1482–1488.10.1016/j.intimp.2009.09.00219748599]Open DOISearch in Google Scholar
[Pourfarzam S, Yaraee R, Hassan ZM, Yarmohammadi ME, Faghihzadeh S, Soroush MR, Fallahi F, Ardestani SK, Ebtekar M, Moaiedmohseni S, Naghizadeh MM, Ghasemi H, Shams J, Ghazanfari T. (2013). Chemokines, MMP-9 and PMN elastase in spontaneous sputum of sulfur mustard exposed civilians: Sardasht-Iran Cohort Study. Int Immunopharmacol17: 958–963.10.1016/j.intimp.2012.12.01523370297]Open DOISearch in Google Scholar
[Procianoy RS, Silveira RC. (2004). The role of sample collection timing on interleukin-6 levels in early-onset neonatal sepsis. J Pediatr (Rio J)80: 407–410.10.2223/1226]Open DOISearch in Google Scholar
[Rahmani H, Javadi I, Shirali S. (2016). Respiratory complications due to sulfur mustard exposure. Int J Curr Res Acad Rev4(6): 143–149.]Search in Google Scholar
[Rahmani H, Javadi I, Shirali S. (2017). Evaluation of serum levels of interleukin-6 and C-reactive protein in mustard lung patients and its relationship with pulmonary complications. Minerva Pneumologica56: 84–89.]Search in Google Scholar
[Reid MB, Lannergren J, Westerblad H. (2002). Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med166: 479–484.]Search in Google Scholar
[Rezaian GR, Emad A, Ghayumi MA, Rezaian S, Zare N. (2008). Exercise intolerance and chronotropic impairment-The long-term cardiovascular sequelae of mustard gas exposure: A paired-comparative study. Environ Toxicol Pharmacol26: 212–215.10.1016/j.etap.2008.03.01521783913]Open DOISearch in Google Scholar
[Riahi-Zanjani B, Balali-Mood M, Mousavi SR, Karimi G, Sadeghi M, Shirmast E, Mahmoudi M. (2014). Serum cytokine profiles of Khorasan veterans 23 years after sulfur mustard exposure. Cytokine70: 161–164.10.1016/j.cyto.2014.07.24825138016]Open DOISearch in Google Scholar
[Rohani A, Akbari V, Moghadam FT. (2010). A case control study of cardiovascular health in chemical war disabled Iranian victims. Indian J Crit Care Med14: 109–112.10.4103/0972-5229.74168302182521253343]Open DOISearch in Google Scholar
[Rutten FH, Moons K G, Cramer MJ, Grobbee DE, Zuithoff NP, Lammers JW, Hoes AW. (2005). Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ331: 1379.]Search in Google Scholar
[Sabourin CL, Danne MM, Buxton KL, Casillas RP, Schlager JJ. (2002). Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol16: 263–272.10.1002/jbt.1005012481301]Open DOISearch in Google Scholar
[Samaha HMS, Elsaid AR, NasrEldin E. (2015). Total serum IgE level in COPD patients. Egypt J Chest Dis Tuberc64(3): 573–577.]Search in Google Scholar
[Sapey E, Ahmad A, Bayley D, Newbold P, Snell N, Rugman P, Stockley RA. (2009). Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol29(4): 508–516.]Search in Google Scholar
[Shahriary A, Mehrani H, Ghanei M, Parvin S. (2015). Comparative proteome analysis of peripheral neutrophils from sulfur mustard-exposed and COPD patients. J Immunotoxicol12: 132–139.]Search in Google Scholar
[Shahriary A, Panahi Y, Shirali S, Rahmani H. (2017). Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis. Postepy Dermatol Alergol.34(3): 192–198.]Search in Google Scholar
[Shahriary A, Rahmani H. (2017). Need to study of systemic markers changes in acute phase of respiratory complication due to sulfur mustard. Toxin Reviews36(3): 261–263.]Search in Google Scholar
[Sheikhi MA, Rahmani H. (2016). Inflammatory statuses of non-smoker mustard lung patient candidate for coronary artery bypass grafting surgery. Int J Pharm Res Allied Sci5: 194–195.]Search in Google Scholar
[Sheu B. (2008). Levels of neutrophils stimulation and matrix Metalloprotease in plasma of individuals with elevated blood pressure and acute/long-term exercise: ProQuest.]Search in Google Scholar
[Shohrati M, Amini-Harandi A, Najafian B, Saburi A, Ghanei M. (2014a). The role of serum level of interleukin-6 i n severity of pulmonary complications of sulfur mustard injuries. Iran J Med Sci39: 382–386.]Search in Google Scholar
[Shohrati M, Ghanei M, Shamspour N, Jafari M, Khasmakhi MNA. (2009). Extra cellular Superoxide Dismutase activity in lung injuries due to Sulfur Mustard. J Qazvin Uni Med Sci12: 5–11.]Search in Google Scholar
[Shohrati M, Haji Hosseini R, Esfandiari MA, Najafian N, Najafian B, Golbedagh A. (2014b). Serum matrix metalloproteinase levels in patients exposed to sulfur mustard. Iran Red Crescent Med J16: e15129.10.5812/ircmj.15129400544224829780]Search in Google Scholar
[Shrivastava AK, Singh HV, Raizada A, Singh SK. (2015). C-reactive protein, inflammation and coronary heart disease. The Egyptian Heart Journal67(2): 89–97.]Search in Google Scholar
[Schols AM. (2002). Pulmonary cachexia. Int J Cardiol85: 101–110.]Search in Google Scholar
[Schumacher A, Liebers U, John M, Gerl V, Meyer M, Witt C, Wolff G. (2005). P-selectin glycoprotein ligand-1 (PSG L-1) is up-regulated on leucocytes from patients with chronic obstructive pulmonary disease. Clin Exp Immunol142(2): 370–376.]Search in Google Scholar
[Schunemann HJ, Dorn J, Grant BJ, Winkelstein W, Trevisan M. (2000). Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. CHEST Journal118: 656–664.10.1378/chest.118.3.65610988186]Open DOISearch in Google Scholar
[Schwartz J, Weiss ST. (1990). Dietary factors and their relation to respiratory symptoms the second national health and nutrition examination survey. Am J Epidemiol132(1): 67–76.]Search in Google Scholar
[Schwartz J, Weiss ST. (1994). Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am J Clin Nutr59(1): 110–114.]Search in Google Scholar
[Siebenlist U, Brown K, Claudio E. (2005). Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immuno l5: 435–445.]Search in Google Scholar
[Sies H, Stahl W. (1995). Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr62(6 Suppl): 1315S–1321S.10.1093/ajcn/62.6.1315S7495226]Open DOISearch in Google Scholar
[Sin DD, Man SF. (2005). Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol83: 8–13.]Search in Google Scholar
[Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. (2003). Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax58: 752–756.]Search in Google Scholar
[Strachan DP, Cox BD, Erzinclioglu SW, Walters DE, Whichelow MJ. (1991). Ventilatory function and winter fresh fruit consumption in a random sample of British adults. Thorax46: 624–629.10.1136/thx.46.9.6244633431948789]Open DOISearch in Google Scholar
[Strieter RM, Kunkel SL, Bone RC. (1993). Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med21: S447–463.10.1097/00003246-199310001-000068403983]Open DOISearch in Google Scholar
[Tabak C, Feskens EJ, Heederik D, Kromhout D, Menotti A, Blackburn HW. (1998). Fruit and fish consumption: a possible explanation for population differences in COPD mortality (The Seven Countries Study). Eur J Clin Nutr52: 819–825.10.1038/sj.ejcn.16006539846595]Open DOISearch in Google Scholar
[Tsuruta J, Sugisaki K, Dannenberg AM, Jr., Yoshimura T, Abe Y, Mounts P. (1996). The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation20: 293–318.]Search in Google Scholar
[Vaillant P, Menard O, Vignaud JM, Martinet N, Martinet Y. (1996). The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis51: 145–152.]Search in Google Scholar
[Visse R, Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res92: 827–839.10.1161/01.RES.0000070112.80711.3D12730128]Open DOISearch in Google Scholar
[Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Gulsvik A, Bakke PS. (2008). Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med102: 399–406.]Search in Google Scholar
[Weinberger B, Laskin JD, Sunil VR, Sinko PJ, Heck DE, Laskin DL. (2011). Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity. Pulm Pharmacol Ther24: 92–99.10.1016/j.pupt.2010.09.004303429020851203]Open DOISearch in Google Scholar
[Wouters EF, Creutzberg EC, Schols AM. (2002). Systemic effects in COPD. CHEST Journal121: 127S–130S.]Search in Google Scholar
[Wright JG, Christman JW. (2003). The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med2: 211–219.]Search in Google Scholar
[Wu S, Chen P, Jiang X, Liu Z. (2005). C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases. Zhong Nan Da Xue Xue Bao Yi Xue Ban30(4): 444–446. [in Chinese]]Search in Google Scholar
[Yaraee R, Ghazanfari T, Ebtekar M, Ardestani SK, Rezaei A, Kariminia A, Faghihzadeh S, Mostafaie A, Vaez-Mahdavi MR, Mahmoudi M. (2009a). Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20years after sulfur mustard exposure: Sardasht-Iran cohort study. Int Immunopharmacol9(13–14): 1466–1470.10.1016/j.intimp.2009.09.00119747989]Search in Google Scholar
[Yaraee R, Ghazanfari T, Faghihzadeh S, Mostafaie A, Soroush MR, Inai K, Foroutan A, Shams J, Naghizadeh MM, Hassan Z M. (2009b). Alterations in the serum levels of soluble L, P and E-selectin 20years after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol.9(13–14): 1477–1481.10.1016/j.intimp.2009.08.02419733695]Search in Google Scholar
[Yaraee R, Hassan ZM, Pourfarzam S, Rezaei A, Faghihzadeh S, Ebtekar M, Soroush M-R, Ardestani SK, Kazemi H, Mahmoudi M. (2013). Fibrinogen and inflammatory cytokines in spontaneous sputum of sulfur-mustard-exposed civilians—Sardasht-Iran Cohort Study. Int Immunopharmacol17(3): 968–973.10.1016/j.intimp.2012.12.02423375935]Open DOISearch in Google Scholar
[Zakerimoghadam M, Tavasoli K, Nejad AK, Khoshkesht S. (2011). The effect of breathing exercises on the fatigue levels of patients with chronic obstructive pulmonary disease. Acta Med Indones43: 29–33.]Search in Google Scholar
[Zandieh T, Marzban S, Tarabadi F, Ansari H. (1990). Defects of cell-mediated-immunity in mustard gas injury after years. Scand J Immunol32(4): 423.]Search in Google Scholar
